• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    1.42 Down 0.04(2.74%) 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development13,114  8,425  5,688  
    Selling General and Administrative6,965  7,005  6,416  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (20,079) (15,430) (12,104)
    Income from Continuing Operations
    Total Other Income/Expenses Net52  42  16  
    Earnings Before Interest And Taxes(20,027)(15,388)(12,088)
    Interest Expense -   -   -  
    Income Before Tax(20,027)(15,388)(12,088)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(20,027)(15,788)(12,088)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (20,027) (15,788) (12,088)
    Preferred Stock And Other Adjustments(1,097)(1,172)(9,859)
    Net Income Applicable To Common Shares (21,124) (16,960) (21,947)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.